Pathophysiologically, the development of T2DM is currently understood as a continuous process with multiple steps ranging from elevated insulin secretion under euglycaemic conditions, followed by increased insulin resistance, decreasing β-cell mass, and breakdown of the gluco-homeostasis [17]. The gene discussed is INS; the disease is type 2 diabetes mellitus.